🇺🇸 COLUMBIA UNIVERSITY ANTI-ISRAEL GROUP POSTS “DEATH TO AMERICA” IN PERSIANCUAD, the student group that organized Columbia’s pro-Palestinian encampment, posted “Marg bar Amrika” on X following the killing of Iran’s Supreme Leader Khamenei.X removed the post, but CUAD said “the sentiment still stands.”Columbia University does not recognize CUAD as an official student organization and has no affiliation with the group. ...

Columbia University student who was detained after immigration agents allegedly used false pretenses to enter campus residence has been released. https://t.co/JqAlipyHuX https://t.co/2cMFScQGyJ ...

Columbia University said that it admitted a student to its dental school via an "irregular process" that coincided with fundraising solicitations by former faculty and alumni to disgraced financier Jeffrey Epstein https://t.co/VGGdqcbxbh ...

Exclusive: Jennifer Mnookin would be Columbia University’s fourth leader in three years. https://t.co/0WwMtHbkAR ...

Columbia University extended its search for a new president as it seeks to find a permanent replacement after losing two leaders in the past 16 months. https://t.co/HzDnJIqrkd ...

Dan Och’s family office hired an executive from Columbia University’s endowment to manage its investments, joining a wave of billionaires sourcing staff from some of the world’s largest nonprofit organizations https://t.co/8lUIVxYmkK ...

Market Manipulation - Polymarket's activity volume has been significantly inflated by wash trading [1] - Wash trading involves users rapidly buying and selling the same contracts [1] Research Findings - Columbia University researchers conducted a new study on Polymarket's trading activity [1]

Big Tech's Dominance and AI - Big tech companies have entrenched their power, especially in the AI age, raising concerns about their potential to dominate the economy and limit opportunities for others [2][3] - The central question is whether AI will threaten tech platforms or be used by them to solidify their dominance [5] - Government scrutiny is needed to prevent big tech companies from controlling AI challengers and insulating their monopolies [9][10] Antitrust and Competition - The costs of monopolies are increasing extraction from various sectors, such as advertising and Amazon sellers [7][8] - Government should provoke competition among big tech giants to foster innovation and progress [8] - Reverse acquisitions by big tech companies of AI companies require closer examination [9] - Natural monopoly is a self-fulfilling prophecy, and challenging dominant companies is crucial for prosperity and innovation [11][12] AI Investment and Circularity - There are concerns that giant investments in AI are primarily aimed at insulating monopolies rather than improving products [12] - The circularity of investments, where companies reinvest excess cash into their customers, needs further examination as it may inhibit competition [13][14][15] National Security and China - Competition at home is the most important industrial policy for the United States, making companies stronger when facing Chinese competitors [21] - Worshipping monopoly sacrifices the United States' own competitiveness [22]

Columbia University is hiring an administrator to advise the school on how “to support Jewish students”. This seems like a fine idea. But just imagine the Trumpian distress if a college swapped “Jewish” for “black”, “female”, “transgender” or “Palestinian” https://t.co/XKqGeXSJGW ...

Core Insights - Silo Pharma, Inc. has received a Japanese patent for its lead asset SPC-15, an intranasal treatment for post-traumatic stress disorder (PTSD), which enhances its intellectual property portfolio [1][2] - The company is collaborating with Columbia University for the development of SPC-15, which is a serotonin 5-HT4 receptor agonist aimed at treating stress-induced psychiatric disorders [2][3] - Silo Pharma's therapeutic focus includes addressing conditions such as PTSD, chronic pain, and central nervous system diseases, with a diverse portfolio of innovative programs [3] Patent and Intellectual Property - The Japan Patent Office granted patent number 7683882 to Columbia University for the invention titled "Prophylactic efficacy of serotonin 4 receptor agonists against stress," which is exclusively licensed to Silo [1] - This patent adds to Silo's international intellectual property portfolio, reinforcing the protection for SPC-15 [2] Product Development - SPC-15 is positioned for potential eligibility under the FDA's streamlined 505(b)(2) regulatory pathway, which could expedite its approval process [2] - The company is conducting preclinical studies in collaboration with Columbia University and holds exclusive global rights for the development and commercialization of SPC-15 [2] Company Overview - Silo Pharma is a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company [3] - The company's portfolio includes other programs such as SP-26 for fibromyalgia and chronic pain, as well as preclinical assets targeting Alzheimer's disease and multiple sclerosis [3]